Table 2.
Cytotoxicity of drugs and drug conjugates in cancer cells
| Drug formulations | IC50 value (μM)* | Enhancement factor |
|---|---|---|
| Etoposide | 12.3 | - |
| HA-ETO | 6.3 | 1.9 |
| CHA-ETO | 3 | 4.2 |
| Salinomycin | 5.1 | - |
| HA-SAL | 3.2 | 1.6 |
| CHA-SAL | 0.9 | 5.4 |
| Curcumin | 19 | - |
| HA-CUR | 70 | 0.3 |
| CHA-CUR | 9 | 2.1 |
Cytotoxicity was measured after 72-h treatment. Enhancement factor shows the drug conjugate efficacy compared to free drug. CHA cytotoxicity (IC50) was > 5 mg/mL. The data are average of eight parallel measurements. Etoposide and salinomycin conjugates were tested in MDA-MB-231/F cells; curcumin conjugates were tested in MIA PaCa-2 cells.